🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 16 of 30

  1. US 8722662

    Heterocyclic compounds

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8703192

    Dosage form containing pantoprazole as active ingredient

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8703758

    Bicyclic compound

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8697874

    Heterocyclic compound and use thereof

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8697097

    Stable solid preparations

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8697865

    Cyclic amide derivative, and its production and use

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8697125

    Tablet preparation without causing a tableting trouble

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8697094

    Stable solid preparations

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8691828

    Thienopyrimidine as CDC7 kinase inhibitors

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8686010

    Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8685924

    Preventives/remedies for stress urinary incontinence and method of screening the same

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8673942

    Fused ring compounds and use thereof

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8669249

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8663694

    Taste masked dosage form containing roflumilast

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8664380

    Heterocyclic compound and use thereof

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8653107

    Fentanyl composition for nasal administration

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8648100

    Roflumilast for the treatment of pulmonary hypertension

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8648079

    Heterocyclic compounds

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8642770

    Indole derivative

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8642649

    Orally dispersible tablet

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8642648

    Orally dispersible tablet

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8642539

    Method for treating a disease characterized by reduced appetite

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8642081

    Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8637079

    Solid preparation comprising alogliptin and pioglitazone

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8637077

    Sustained-release preparation

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8632808

    Taste-masking solid preparation of pioglitazone

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8623405

    Finely divided composition containing poorly water soluble substance

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8618142

    Process for the preparation of roflumilast

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8618290

    HSP90 inhibitors

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8614208

    Fused heterocyclic ring derivative and use thereof

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8609871

    Process for production of optically active amine derivatives

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8609848

    Pyrazolone-derivatives and their use as PDE-4 inhibitors

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8604064

    Process for the preparation of roflumilast

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8598226

    Fused cyclic compounds

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8592598

    Method of producing a crystal of an imidazole compound

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8592597

    Pyrrole compounds

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8592454

    Nitrogen-containing heterocyclic compound and use of same

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8592452

    Cyclic amine compound

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8592431

    Fused ring compound and use thereof

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8592379

    Metastin derivative and use thereof

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8586762

    Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8586571

    Heterocyclic compound

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8575167

    Spiro compounds having stearoyl-CoA desaturase action

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8575154

    Heterocyclic compound and use thereof

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8563730

    Pyrazole and fused pyrazole glucokinase activators

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8563575

    Fused heterocyclic compounds

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8557805

    Fused ring compound and use thereof

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8552037

    Tricyclic compound and pharmaceutical use thereof

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.